Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2562-2565

  Menschik, Monika ^a   Neumüller, Josef ^b   Steiner, Carl Walter ^a   Erlacher, Ludwig ^a   Köller, Markus ^a   Ullrich, Robert ^a   Graninger, Wolfgang ^a   Graninger, Winfried B ^a,c  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c NONE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; APOPTOSIS; ARTICLE; CARTILAGE CELL; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; ORGAN CULTURE; PRIORITY JOURNAL; PUNCH BIOPSY; TOXICITY TESTING;

EID: 0342506803     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2562     Document Type: Article

References (31)

1. Bailly, S., M. Fay, B. Ferrua, and M. A. Gougerot Pocidalo. 1991. Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide-stimulated human monocytes to produce IL-1, IL-6 and tumour necrosis factor-alpha. Clin. Exp. Immunol. 85:331-334.
2. Blanco, F. J., R. L. Ochs, H. Schwarz, and M. Lotz. 1995. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146:75-85.
3. Burkhardt, J. E., M. A. Hill, and W. W. Carlton. 1992. Morphologic and biochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin. Toxicol. Pathol. 20:246-252.
4. Burkhardt, J. E., M. A. Hill, C. H. Lamar, G. N. Smith, Jr., and W. W. Carlton. 1993. Effects of difloxacin on the metabolism of glycosaminoglycans and collagen in organ cultures of articular cartilage. Fundam. Appl. Toxicol. 20:257-263.
5. Burkhardt, J. E., M. A. Hill, J. J. Turek, and W. W. Carlton. 1992. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet. Pathol. 29:230-238.
6. Danisovicova, A., M. Brezina, S. Belan, H. Kayserova, E. Kaiserova, I. Hruskovic, K. Orosova, S. Dluholucky, K. Galova, and E. Matheova. 1994. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy 40: 209-214.
7. Foerster, C. 1994. In vivo and in vitro investigation on the chondrotoxic effect of fiuoroquinolones. Ph.D. thesis. Free University, Berlin, Germany.
8. Ghadially, F. N. 1981. Structure and function of cartilage. Clin. Rheum. Dis. 7:3-26.
9. Gough, A. W., O. B. Kasali, R. E. Sigler, and V. Baragi. 1992. Quinolone arthropathy - acute toxicity to immature articular cartilage. Toxicol. Pathol. 20:436-449.
10. Hayem, G., P. X. Petit, M. Levacher, C. Gaudin, M. F. Kahn, and J. J. Pocidalo. 1994. Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob. Agents Chemother. 38:243-247.
11. Hildebrand, H., G. Kempka, G. Schluter, and M. Schmidt. 1993. Chondrotoxicity of quinolones in vivo and in vitro. Arch. Toxicol. 67:411-415.
12. Kato, M., S. Takada, S. Ogawara, and S. Takayama. 1995. Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo. Antimicrob. Agents Chemother. 39:1979-1983.
13. Kubin, R. 1993. Safety and efficacy of ciprofloxacin in paediatric patients -review. Infection 21:413-421.
14. Linseman, D. A., L. A. Hampton, and D. G. Branstetter. 1995. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fundam. Appl. Toxicol. 28:59-64.
15. Milio, M. C., and S. Campana. 1995. Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis. Pediatr. Med. Chir. 17:53-55.
16. Mont, M. A., S. K. Mathur, C. G. Frondoza, and D. S. Hungerford. 1996. The effects of ciprofloxacin on human chondrocytes in cell culture. Infection 24:151-155.
17. Morales, T. I., and V. C. Hascall. 1989. Effects of interleukin-1 and lipopolysaccharides on protein and carbohydrate metabolism in bovine articular cartilage organ cultures. Connect. Tissue Res. 19:255-275.
18. Pradhan, K. M., N. K. Arora, A. Jena, A. K. Susheela, and M. K. Bhan. 1995. Safety of ciprofloxacin therapy in children: magnetic resonance images, body fluid levels of fluoride and linear growth. Acta Paediatr. 84:555-560.
19. Rusquet, R., M. Bonhommet, and J. C. David. 1984. Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase. Biochem. Biophys. Res. Commun. 121:762-769.
20. Schaad, U. B., E. Sander, J. Wedgwood, and T. Schaffner. 1992. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr. Infect. Dis. J. 11:1047-1049.
21. Schaad, U. B., C. Stoupis, J. Wedgwood, H. Tschaeppeler, and P. Vock. 1991. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr. Infect. Dis. J. 10:723-729.
22. Schaad, U. B., J. Wedgwood, A. Ruedeberg, R. Kraemer, and B. Hampel. 1997. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Pediatr. Infect. Dis. J. 16:106-111.
23. Shakibaei, M., K. Kociok, C. Forster, J. Vormann, T. Gunther, R. Stahlmann, and H. J. Merker. 1996. Comparative evaluation of ultrastructural changes in articular cartilage of ofloxacin treated and magnesium deficient immature rats. Toxicol. Pathol. 24:580-587.
24. Sharpnack, D. D., J. P. Mastin, C. P. Childress, and G. M. Henningsen. 1994. Quinolone arthropathy in juvenile New Zealand white rabbits. Lab. Anim. Sci. 44:436-442.
25. Stahlmann, R. 1991. Cartilage-damaging effect of quinolones. Infection 19(Suppl. 1):S38-46.
26. Stahlmann, R., C. Forster, M. Shakibaei, J. Vormann, T. Gunther, and H. J. Merker. 1995. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob. Agents Chemother. 39:2013-2018.
27. Stahlmann, R., C. Forster, and D. Van Sickle. 1993. Quinolones in children. Are concerns over arthropathy justified? Drug Saf. 9:397-403.
28. Stahlmann, R., H. J. Merker, N. Hinz, I. Chahoud, J. Webb, W. Heger, and D. Neubert. 1990. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch. Toxicol. 64:193-204.
29. Takada, S., M. Kato, and S. Takayama. 1994. Comparison of lesions induced by intra-articular injections of quinolones and compounds damaging cartilage components in rat femoral condyles. J. Toxicol. Environ. Health 42:73-88.
30. Thuong Guyot, M., O. Domarle, J. J. Pocidalo, and G. Hayem. 1994. Effects of fluoroquinolones on cultured articular chondrocytes: flow cytometric analysis of free radical production. J. Pharmacol. Exp. Ther. 271:1544-1549.
31. Wolfson, J. S., and D. C. Hooper. 1991. Overview of fluoroquinolone safety. Am. J. Med. 91:153S-161S.